OBJECTIVE To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF). SETTING 1317 participating sites in 35 countries. PARTICIPANTS 52 057 patients aged 18 years and older with newly diagnosed atrial fibrillation (up to six weeks' duration) and at least one investigator determined stroke risk factor. MAIN OUTCOME MEASURES Comparisons were made between patients who received cardioversion and those who had no cardioversion at baseline, and between patients who received direct current cardioversion and those who had pharmacological cardioversion. Overlap propensity weighting with Cox proportional hazards models was used to evaluate the effect of cardioversion on clinical endpoints (all cause mortality, non-haemorrhagic stroke or systemic embolism, and major bleeding), adjusting for baseline risk and patient selection. RESULTS 44 201 patients were included in the analysis comparing cardioversion and no cardioversion, and of these, 6595 (14.9%) underwent cardioversion at baseline. The propensity score weighted hazard ratio for all cause mortality in the cardioversion group was 0.74 (95% confidence interval 0.63 to 0.86) from baseline to one year follow-up and 0.77 (0.64 to 0.93) from one year to two year follow-up. Of the 6595 patients who had cardioversion at baseline, 299 had a follow-up cardioversion more than 48 days after enrolment. 7175 patients were assessed in the analysis comparing type of cardioversion: 2427 (33.8%) received pharmacological cardioversion and 4748 (66.2%) had direct current cardioversion. During one year follow-up, event rates (per 100 patient years) for all cause mortality in patients who received direct current and pharmacological cardioversion were 1.36 (1.13 to 1.64) and 1.70 (1.35 to 2.14), respectively. OBJECTIVE To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF). SETTING 1317 participating sites in 35 countries. PARTICIPANTS 52 057 patients aged 18 years and older with newly diagnosed atrial fibrillation (up to six weeks' duration) and at least one investigator determined stroke risk factor. MAIN OUTCOME MEASURES Comparisons were made between patients who received cardioversion and those who had no cardioversion at baseline, and between patients who received direct current cardioversion and those who had pharmacological cardioversion. Overlap propensity weighting with Cox proportional hazards models was used to evaluate the effect of cardioversion on clinical endpoints (all cause mortality, non-haemorrhagic stroke or systemic embolism, and major bleeding), adjusting for baseline risk and patient selection. RESULTS 44 201 patients were included in the analysis comparing cardioversion and no cardioversion, and of these, 6595 (14.9%) underwent cardioversion at baseline. The propensity score weighted hazard ratio for all cause mortality in the cardioversion group was 0.74 (95% confidence interval 0.63 to 0.86) from baseline to one year follow-up and 0.77 (0.64 to 0.93) from one year to two year follow-up.Of the 6595 patients who had cardioversion at baseline, 299 had a follow-up cardioversion more than 48 days after enrolment. 7175 patients were assessed in the analysis comparing type of cardioversion: 2427 (33.8%) received pharmacological cardioversion and 4748 (66.2%) had direct current cardioversion. During one year follow-up, event rates (per 100 patient years) for all cause mortality in patients who received direct current and pharmacological cardioversion were 1.36 (1.13 to 1.64) and 1.70 (1.35 to 2.14), respectively. CONCLUSION In this large dataset of patients with recent onset non-valvular atrial fibrillation, a small proportion were treated with cardioversion. Direct current cardioversion was performed twice as often as pharmacological cardioversion, and there appeared to be no major difference in outcome events for these two cardioversion modalities. For the overall cardioversion group, after adjustments for confounders, a significantly lower risk of mortality was found in patients who received early cardioversion compared with those who did not receive early cardioversion. STUDY REGISTRATION ClinicalTrials.gov NCT01090362.
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data / P. Marita Knudsen, H. Trygve S, S. Valentina, R. Petra, V. Saverio, P. Karen S, L.H. Jean-Yves, J. Petr, F. David A, C. Riccardo, A. Dan, C. A J., A.K. Kakkar, J. Bassand, K.A. A Fox, B. J Gersh, S. Z Goldhaber, S. Goto, S. Haas, W. Hacke, L. G Mantovani, F. Misselwitz, A.G. G Turpie, M. van Eickels, F.W. A Verheugt, H. Lucas Luciardi, H. Gibbs, M. Brodmann, F. Cools, A. Carlos Pereira Barretto, S. J Connolly, J. Eikelboom, R. Corbalan, Z. Jing, J. Dalsgaard Nielsen, H. Ragy, P. Raatikainen, H. Darius, M. Keltai, J. Pal Singh Sawhney, Y. Koretsune, C. Jerjes Sánchez Díaz, H. Ten Cate, J. Stepinska, E. Panchenko, T. Wei Lim, B. Jacobson, S. Oh, X. Viñolas, M. Rosenqvist, J. Steffel, P. Angchaisuksiri, A. Oto, A. Parkhomenko, W. Al Mahmeed, S. Z Goldhaber, D. Hu, K. Chen, Y. Zhao, H. Zhang, J. Chen, S. Cao, D. Wang, Y. Yang, W. Li, H. Li, Y. Yin, G. Tao, P. Yang, Y. Chen, S. He, Y. Wang, G. Fu, X. Li, T. Wu, X. Cheng, X. Yan, R. Zhao, M. Chen, L. Xiong, P. Chen, Y. Jiao, Y. Guo, L. Xue, Z. Yang, P. Jadhavm, R. Sarma, G. Kulkarni, P. Chandwani, R. Atulbhai Pothiwala, M. Padinhare Purayil, K. Chawla, V. Annasaheb Kothiwale, B. Raghuraman, V. Madan Vijan, J. Sawhney, G. Bantwal, A. Khan, R. Meena, M. Chopada, S. Abraham, V. Bisne, G. Vijayaraghavan, D. Roy, R. Durgaprasad, A. G Ravi Shankar, S. Kumar, D. Jain, K. Bhargava, V. Kumar, U. Madappa Nagamalesh, R. Kumar Rajput, Y. Koretsune, S. Kanamori, K. Yamamoto, K. Kumagai, Y. Katsuda, K. Yoshida, F. Toyota, Y. Mizuno, I. Misumi, H. Noguchi, S. Ando, T. Suetsugu, M. Minamoto, H. Oda, S. Adachi, K. Chiba, H. Norita, M. Tsuruta, T. Koyanagi, K. Yamamoto, H. Ando, T. Higashi, M. Okada, S. Azakami, S. Komaki, K. Kumeda, T. Murayama, J. Matsumura, Y. Oba, R. Sonoda, K. Goto, K. Minoda, Y. Haraguchi, H. Suefuji, H. Miyagi, H. Kato, T. Nakamura, T. Nakamura, H. Nandate, R. Zaitsu, Y. Fujiura, A. Yoshimura, H. Numata, J. Ogawa, Y. Kamogawa, K. Murakami, Y. Wakasa, M. Yamasawa, H. Maekawa, S. Abe, H. Kihara, S. Tsunoda, K. Saito, H. Tachibana, I. Oba, T. Kuwahata, S. Higa, M. Gushiken, T. Eto, H. Chibana, K. Fujisawa, Y. Shiga, H. Sumi, T. Nagatomo, Y. Atsuchi, T. Nagoshi, K. Sanno, F. Hoshino, N. Yokota, M. Kameko, T. Tabuchi, M. Ishizawa, Y. Fujiura, D. Ikeda, T. Seto, T. Iwao, N. Ishioka, K. Oshiro, K. Tsuchida, Y. Hatori, M. Takeuchi, H. Takezawa, S. Nagano, M. Iwaki, Y. Nakamura, N. Miyamoto, T. Taguchi, K. Ashida, N. Yoshizawa, J. Agata, S. Matsukawa, O. Arasaki, S. Fukuoka, H. Murakami, K. Mishima, Y. Hata, I. Sakuma, K. Obunai, I. Takamura, M. Akutsu, T. Unoki, Y. Go, M. Ikemura, S. Morii, S. Marusaki, H. Doi, M. Tanaka, T. Kusumoto, S. Kakinoki, C. Ogurusu, K. Murata, M. Shimoyama, M. Nakatsuka, Y. Kitami, Y. Nakamura, H. Oda, R. Oyama, M. Ageta, T. Mita, K. Nagao, T. Mito, J. Minami, M. Abe, M. Fujii, M. Okawa, T. Fujito, T. Taniguchi, T. Ko, H. Kubo, M. Imamaki, M. Akiyama, T. Ueda, H. Odakura, M. Inagaki, Y. Katsube, A. Nakata, S. Tomimoto, M. Shibuya, M. Nakano, K. Ito, M. Matsuta, M. Ishiguro, T. Minagawa, M. Wada, H. Mukawa, M. Mizuguchi, F. Okuda, T. Kimura, K. Taga, M. Techigawara, M. Igarashi, H. Watanabe, T. Seo, S. Hiramitsu, H. Hosokawa, M. Hoshiai, M. Hibino, K. Miyagawa, H. Horie, N. Sugishita, Y. Shiga, A. Soma, K. Neya, T. Yoshida, K. Akahane, S. Adachi, C. Takanaka, T. Ueda, S. Matsui, H. Kanda, M. Kaneko, S. Nagasaka, A. Taguchi, S. Toru, K. Saito, A. Miyashita, H. Sasaguri, J. Nariyama, T. Hatsuno, T. Iwase, K. Sato, K. Kawai, T. Kotani, T. Tsuji, H. Sakai, K. Nishino, K. Ikeda, K. Maeda, T. Shinozuka, T. Inoue, K. Kawakami, H. Kitazumi, T. Takagi, M. Hamaoka, J. Kojima, A. Sasaki, Y. Tsuchiya, T. Betsuyaku, K. Higuchi, M. Honda, K. Hasegawa, T. Baba, K. Mineoi, T. Koeda, K. Hirasawa, T. Kumazaki, A. Nakagomi, E. Otaki, T. Shindo, H. Hirayama, C. Sugimoto, T. Yamagishi, I. Mizuguchi, K. Sezaki, I. Niwa, K. Takenaka, O. Iiji, K. Taya, H. Kitazawa, S. Ueda, H. Kakuda, T. Ono, S. Oriso, J. Kamata, T. Nanke, I. Maeda, Y. Matsuura, H. Teragawa, Y. Maruyama, K. Takei, H. Horie, T. Kito, H. Asano, K. Matsushita, M. Nakamura, T. Washizuka, T. Yoshida, M. Sawano, S. Arima, H. Arai, H. Shinohara, H. Takai, N. Furukawa, A. Ota, K. Yamamoto, K. Aoki, T. Yamamoto, T. Kasai, S. Suzuki, S. Suzuki, N. Shibata, M. Watanabe, Y. Nishihata, T. Arino, M. Okuyama, T. Wakiyama, T. Kato, Y. Sasagawa, T. Tana, Y. Hayashi, S. Hirota, Y. Abe, Y. Saito, H. Uchiyama, H. Takeda, H. Ono, S. Tohyo, N. Hanazono, S. Miyajima, H. Shimono, T. Aoyama, Y. Shozawa, Y. Niijima, O. Murai, O. Murai, H. Inaba, K. Nomura, M. Nozoe, K. Suzuki, T. Furukawa, T. Shiraiwa, N. Ito, S. Nagai, K. Sato, S. Nakahara, Y. Shimoyama, N. Ohara, T. Kozuka, H. Okita, M. Endo, T. Goto, M. Hirose, E. Nagata, N. Nakanishi, T. Mori, S. Seki, K. Okamoto, O. Moriai, Y. Emura, T. Fukuda, H. Date, S. Kawakami, S. Nagai, Y. Ueyama, T. Fudo, M. Imaizumi, T. Ogawa, S. Take, H. Ikeda, H. Nishioka, N. Sakamoto, K. Ikeoka, N. Wakaki, M. Abe, J. Doiuchi, T. Kira, M. Tada, K. Tsuzaki, N. Miura, Y. Fujisawa, W. Furumoto, S. Suzuki, A. Fujisawa, R. Nakamura, H. Komatsu, R. Fujiki, S. Kawano, K. Nishizawa, Y. Kato, J. Azuma, K. Yasui, T. Amano, Y. Sekine, T. Honzawa, Y. Koshibu, Y. Sakamoto, Y. Seta, S. Miyaguchi, K. Morishita, Y. Samejima, T. Sasaki, F. Iseki, T. Kobayashi, H. Kano, J. Kim, H. Yamaguchi, Y. Takagi, Y. Onuki Pearce, Y. Suzuki, T. Fukui, T. Nakayama, H. Kanai, Y. Kawano, T. Ino, H. Miyoshi, Y. Miyamoto, M. Shigekiyo, S. Ono, Y. Kawano, Y. Okamoto, S. Ubukata, K. Kodera, T. Oriuchi, N. Matsumoto, K. Inagaki, A. Iseki, T. Yoshida, T. Goda, T. Katsuki, A. Sato, E. Mori, T. Tsubokura, H. Shudo, S. Fujimoto, T. Katsuya, Y. Furukawa, H. Hosokawa, J. Narumi, K. Yamamoto, M. Owari, T. Inakura, T. Anno, K. Shirakawa, C. Keong Ching, T. Wei Lim, D. Foo, K. Wong, T. Yuyang, S. Oh, H. Nam Park, W. Kim, H. Lee, S. Jang, D. Hyeok Kim, J. Kim, D. Ryu, J. Shim, D. Kim, D. Ju Choi, Y. Seog Oh, M. Cho, H. Kim, H. Jeon, D. Shin, S. Weon Park, H. Ki Park, S. Han, J. Hoon Sung, H. Park, G. Nam, Y. Keun On, H. Euy Lim, J. Kwak, T. Cha, T. Jong Hong, S. Hoon Park, J. Han Yoon, N. Kim, K. Kim, B. Chun Jung, G. Hwang, C. Kim, S. Rungaramsin, P. Katekangplu, P. Khunrong, T. Bunyapipat, W. Wongcharoen, P. Kaewsuwanna, K. Siriwattana, W. Tiyanon, S. Pattanaprichakul, K. Likittanasombat, D. Cholsaringkarl, W. Boonyapisit, S. Cheewatanakornkul, S. Silaruks, P. Hutayanon, S. Chawanadelert, P. Chattranukulchai, B. Chatlaong, Y. Santanakorn, K. Kanokphatcharakun, P. Mongkolwongroj, S. Jai-Aue, O. Komson, A. Altun, A. Aydinlar, R. Topsakal, Z. Ongen, S. Acikel, D. Yildiray Sahin, O. Yilmaz, M. Birhan Yilmaz, H. Pekdemir, M. Demir, M. Sucu, L. Sahiner, A. Oto, M. Ersanli, E. Okuyan, D. Aras, F. Rolandi, A. Cesar Ingaramo, G. Alberto Sambadaro, V. Fernandez Caputi, H. Luciardi, S. Graciela Berman, P. Dragotto, A. Javier Kleiban, N. Centurion, R. Andres Ahuad Guerrero, L. Adalberto Di Paola, R. Dario Dran, J. Egido, M. Jose Fosco, V. Alfredo Sinisi, L. Rodolfo Cartasegna, O. Gomez Vilamajo, J. Luis Ramos, S. Sassone, G. Zapata, D. Conde, G. Giacomi, A. Alfredo Fernandez, M. Alberto Berli, F. Ferroni, D. Celestino Sobral Filho, J. Jaber, L. Vidal Armaganijan, C. Roberto Frack Costantini, A. Steffens, W. Kunz Sebba Barroso de Souzaem, J. David de Souza Neto, J. Márcio Ribeiro, M. Silveira Teixeira, P. Rossi, L. Pires, D. Moreira, J. Carlos Moura Jorge, A. Menezes Lorga Filho, L. Bodanese, M. Westerlund Montera, C. Henrique Del Carlo, J. Abdalla Saad, F. Augusto Alves da Costa, R. Lopes, G. Roberto de Araújo, E. Roberto Manenti, J. Francisco Kerr Saraiva, J. Carlos Ferreira Braga, A. Negri, C. Moncada, D. Precoma, F. Roquette, G. Reis, R. Álvaro Ramos Filho, E. Lanna Figueiredo, R. Vieira Botelho, C. Munhoz da Fontoura Tavares, H. Carlos Finimundi, A. Kochi, C. Cássio Broilo França, F. Alban, G. Bernardo Aranha Rosito, J. Batista de Moura Xavier Moraes Junior, R. Tadeu Tumelero, L. Maia, R. Simões de Almeida, N. Carter do Carmo Borges, L. Gustavo Gomes Ferreira, R. Corbalán, B. Aleck Joseh Stockins Fernandez, H. Montecinos, F. Lanas, M. Larico Gómez, C. Astudillo, C. Conejeros, P. Marin Cuevas, A. Forero, C. Bugueño Gutiérrez, J. Aguilar, S. Potthoff Cardenas, G. Eggers, C. Houzvic, C. Rey, G. Arriagada, G. Charme Vilches, J. Jaime Illescas Diaz, R. Leal Cantu, M. Guadalupe Ramos Zavala, R. Cabrera Jardines, N. Espinola Zavaleta, E. Lopez Rosas, G. Antonio Llamas Esperón, G. Pozas, E. Cardona Muñoz, N. Matadamas Hernandez, A. Leyva Rendon, N. Garcia Hernandez, M. de Los Rios Ibarra, L. Ramon Virgen Carrillo, D. Lopez Villezca, C. Hernandez Herrera, J. Jose Lopez Prieto, R. Gaona Rodriguez, E. Villeda Espinosa, D. Flores Martinez, J. Velasco Barcena, O. Fierro Fierro, I. Rodriguez Briones, J. Luis Leiva Pons, H. Alvarez Lopez, R. Olvera Ruiz, C. Gerardo Cantu Brito, E. Julian Jose Roberto Chuquiure Valenzuela, R. Reyes Sanchez, A. Esteban Bazzoni Ruiz, O. Martin Lopez Ruiz, R. Arriaga Nava, J. David Morales Cerda, P. Fajardo Campos, M. Benavides Gonzalez, M. Brodmann, K. Lenz, C. Hagn, J. Foechterle, H. Drexel, K. Huber, A. Podczeck-Schweighofer, M. Winkler, B. Schneeweiss, A. Gegenhuber, W. Lang, S. Eichinger-Hasenauer, P. Kaserer, J. Sykora, H. Rasch, B. Strohmer, L. Capiau, G. Vervoort, B. Wollaert, F. Cools, G. Hollanders, J. Vercammen, D. Faes, Y. Balthazar, M. Delforge, O. Xhaet, H. Striekwold, J. Thoeng, K. Hermans, G. Mairesse, W. Anné, I. Blankoff, M. Beutels, S. Verstraete, P. Vandergoten, P. Purnode, P. Godart, T. Boussy, P. Desfontaines, A. Heyse, J. Voet, A. De Wolf, E. Zidkova, R. Spacek, V. Machova, O. Ludka, J. Olsr, L. Kotik, B. Racz, R. Ferkl, J. Hubac, I. Kotik, Z. Monhart, H. Burianova, O. Jerabek, J. Pisova, I. Petrova, V. Dedek, M. Honkova, P. Podrazil, P. Reichert, J. Spinar, M. Novak, V. Durdil, K. Plocova, J. Lastuvka, J. Nielsen, S. Husted, H. Dominguez, U. Hintze, S. Rasmussen, N. Sygehus, A. Bremmelgaard, J. Markenvard, J. Børger, J. Solgaard, E. Eriksen, T. Løkkegaard, M. Bruun, J. Mertz, M. Schou, H. Dominguez, M. Olsen, P. Raatikainen, K. E Juhani Airaksinen, F. Paganelli, J. Ohayon, F. Casassus, J. Le Heuzey, M. Galinier, Y. Gottwalles, P. Loiselet, J. Muller, M. Bassel Koujan, A. Marquand, S. Destrac, O. Piot, N. Delarche, J. Cebron, M. Guenoun, D. Guedj-Meynier, A. G Lokesh, M. Zuber, P. Amarenco, E. Ellie, J. Kadouch, P. Fournier, J. Huberman, N. Lemaire, G. Rodier, X. Vandamme, I. Sibon, J. Neau, M. Hélène Mahagne, A. Mielot, M. Bonnefoy, J. Churet, V. Navarre, F. Sellem, G. Monniot, J. Boyes, B. Doucet, M. Martelet, D. Obadia, B. Crousillat, J. Mouallem, E. Bearez, J. Philippe Brugnaux, A. Fedorowsky, P. Nazeyrollas, J. Berneau, F. Chemin, S. Schellong, H. Darius, G. Koeniger, A. Kopf, U. Gerbaulet, B. Kellner, T. Schaefer, J. Purr, E. Eißfeller, H. Zauzig, P. Riegel, C. Axthelm, G. Heinz, H. Menke, A. Pustelnik, S. Zutz, W. Eder, G. Rehling, D. Glatzel, N. Ludwig, P. Sandow, H. Wiswedel, C. Wildenauer, S. Schoen, T. Schwarz, A. Babyesiza, M. Kropp, H. Zimny, F. Kahl, A. Caspar, S. Omankowsky, T. Laessig, H. Hartmann, G. Lehmann, H. Bindig, G. Hergdt, D. Reimer, J. Hauk, H. Michel, P. Dres, W. Erdle, W. Dorsch, J. Dshabrailov, K. Rapp, R. Vormann, T. Mueller, P. Mayer, U. Horstmeier, V. Eissing, H. Hey, H. Leuchtgens, V. Lilienweiss, H. Mueller, C. Schubert, H. Lauer, T. Buchner, G. Brauer, S. Kamin, K. Mueller, S. Baumbach, M. Abdel-Qader, H. Ebert, C. Schwencke, P. Bernhardt, L. Karolyi, B. Sievers, W. Haverkamp, J. Roehnisch, A. Vertes, G. Szantai, A. Matoltsy, N. Kanakaridisz, Z. Boda, E. Kis, B. Gaszner, F. Juhasz, G. Juhasz, S. Kancz, Z. Laszlo, Z. May, B. Merkely, E. Noori, T. Habon, P. Polgar, G. Szalai, S. Vangel, A. Nagy, G. Engelthaler, J. Ferenczi, M. Egyutt, G. Martini, L. Maria Cristina, E. Tiraferri, R. Santoro, S. Testa, G. Di Minno, M. Moia, T. Maria Caimi, M. Tessitori, G. Agnelli, R. Cappelli, D. Poli, R. Quintavalla, F. Cosmi, R. Fanelli, V. Oriana, R. Reggio, R. Santi, L. Pancaldi, R. De Cristofaro, G. Guazzaloca, A. De Blasio, J. Salerno Uriate, F. Lillo, E. Maria Pogliani, G. Bilo, M. Accogli, A. Mariani, M. Feola, A. Raisaro, L. Fattore, A. Mauric, F. Germini, L. Tedeschi, M. Settimi, S. Nicoli, P. Ricciarini, A. Argena, P. Ronchini, C. Bulla, F. Tradati, M. Volpe, M. D'Avino, M. Grazia Bongiorni, S. Severi, A. Capucci, C. Lodigiani, E. Salomone, G. Serviddio, C. Tondo, G. Ambrosio, P. Golino, C. Mazzone, S. Iacopino, H. Ten Cate, J. H Ruiter, A. Lucassen, H. Adriaansen, M. Bongaerts, M. Pieterse, C. van Guldener, J. Herrman, S.H.K.P. R Nierop, P. Hoogslag, W. Hermans, B. E Groenemeijer, W. Terpstra, C. Buiks, L.V. A Boersma, E. Berge, P. Anton Sirnes, E. Gjertsen, T. Hole, K. Erga, A. Hallaråker, G. Skjelvan, A. Østrem, B. Ghezai, A. Svilaas, P. Christersson, T. Øien, S. Høegh Henrichsen, J. Erik Otterstad, J. Berg-Johansen, J. Stepinska, A. Gieroba, M. Biedrzycka, M. Ogorek, B. Wozakowska-Kaplon, K. Loboz-Grudzien, W. Supinski, J. Kuzniar, R. Zaluska, J. Hiczkiewicz, L. Swiatkowska-Byczynska, L. Kucharski, M. Gruchala, P. Minc, M. Olszewski, G. Kania, M. Krzciuk, Z. Lajkowski, B. Ostrowska-Pomian, J. Lewczuk, E. Zinka, A. Karczmarczyk, M. Chmielnicka-Pruszczynska, I. Wozniak-Skowerska, G. Opolski, M. Bronisz, M. Ogorek, G. Glanowska, P. Ruszkowski, G. Skonieczny, R. Sciborski, B. Okopien, P. Kukla, K. Galbas, K. Cymerman, J. Jurowiecki, P. Miekus, W. Myszka, S. Mazur, R. Lysek, J. Baszak, T. Rusicka-Piekarz, G. Raczak, E. Domanska, J. Nessler, J. Lesnik, V. Eltishcheva, R. Libis, G. Kamalov, D. Belenky, L. Egorova, A. Khokhlov, E. Yakupov, D. Zateyshchikov, O. Barbarash, O. Miller, E. Mazur, K. Zrazhevskiy, T. Novikova, Y. Moiseeva, E. Polkanova, K. Sobolev, M. Rossovskaya, Y. Shapovalova, A. Kolesnikova, K. Nikolaev, O. Zemlianskaia, A. Zateyshchikova, V. Kostenko, S. Popov, M. Poltavskaya, A. Edin, E. Aleksandrova, O. Drapkina, A. Vishnevsky, O. Nagibovich, P. Chizhov, S. Rachkova, M. Sergeev, B. Kurylo, A. Ushakov, X. Vinolas, P. Alvarez Garcia, M. Fernanda Lopez Fernandez, L. Tercedor Sanchez, S. Tranche Iparraguirre, P. Toran Monserrat, E. Marquez Contreras, J. Isart Rafecas, J. Motero Carrasco, P. Garcia Pavia, C. Gomez Pajuelo, L. Miguel Rincon Diaz, L. Fernando Iglesias Alonso, A. Grande Ruiz, J. Merce Klein, J. Ramon Gonzalez Juanatey, I. Monte Collado, H. Palacin Piquero, C. Brotons Cuixart, E. Fernandez Escobar, J.B. I Llibre, C. Corros Vicente, M. Vida Gutierrez, F. Epelde Gonzalo, C. Alexandre Almeida Fernandez, E. Martinez Navarro, J. Isart Rafecas, J. Jose Montero Alia, M. Barreda Gonzalez, M. Angels Moleiro Oliva, J. Iglesias Sanmartin, M. Jimenez Gonzalez, M. Del Mar Rodriguez Alvarez, J. Herreros Melenchon, T. Ripoll Vera, M. Jimenez Navarro, M. Vazquez Caamano, M. Fe Arcocha Torres, G. Marcos Gomez, A. Iniguez Romo, M. Angel Prieto Diaz, M. Rosenqvist, A. Wirdby, J. Lindén, K. Henriksson, M. Elmersson, A. Egilsson, U. Börjesson, G. Svärd, B. Liu, A. Lindh, L. Olsson, M. Gustavsson, L. Andersson, L. Benson, C. Bothin, A. Hajimirsadeghi, B. Martinsson, M. Ericsson, Å. Ohlsson, H. Lindvall, P. Svensson, K. Thörne, H. Händel, P. Platonov, F. Bernsten, I. Timberg, M. Crisby, J. Karlsson, A. Andersson, L. Malmqvist, J. Engdahl, J. Thulin, A. Hot-Bjelak, S. Jensen, P. Stalby, J. Steffel, J. Debrunner, J. H Beer, D. Shah, I. Rudyk, V. Tseluyko, O. Karpenko, S. Zhurba, I. Kraiz, O. Parkhomenko, I. Kupnovytska, N. Seredyuk, Y. Mostovoy, O. Ushakov, O. Koval, I. Kovalskiy, Y. Svyshchenko, O. Sychov, M. Stanislavchuk, A. Yagensky, S. Tykhonova, I. Fushtey, W. Murdoch, N. Chauhan, D. Goodwin, L. Lumley, R. Patel, P. Saunders, B. Wong, A. Cameron, P. Saunders, N. Patel, P. Jhittay, A. Ross, M. S Kainth, K. Ladha, K. Douglas, G. Pickavance, J. Mcdonnell, L. Handscombe, T. Gooding, H. Wagner, C. Bradshaw, C. Bromham, K. Jones, S. Suryani, R. Coates, B. Sarai, W. Willcock, S. Sircar, J. Cairns, A. Gilliand, R. Bilas, E. Strieder, P. Hutchinson, A. Wakeman, M. Stokes, G. Kirby, B. Vishwanathan, N. Bird, P. Evans, M. Clark, J. Bisatt, J. Litchfield, E. Fisher, T. Fooks, R. Kelsall, N. Paul, E. Alborough, M. Aziz, C. Ramesh, P. Wilson, S. Franklin, S. Fairhead, J. Thompson, H. Chowan, G. Taylor, D. Tragen, M. Parfitt, C. Seamark, C. Paul, M. Richardson, A. Jefferies, H. Sharp, H. Jones, C. Giles, M. Bramley, P. Williams, J. Aldegather, S. Wetherell, W. Lumb, P. Evans, F. Scouller, N. Macey, S. Rogers, Y. Stipp, R. West, P. Pinney, P. Wadeson, J. Matthews, P. Pandya, A. Gallagher, T. Railton, E. Davies, J. Mcclure, M. Jacobs, C. Hutton, R. Thompson, B. Sinha, K. Butter, S. Barrow, H. Little, D. Russell, U. Choudhary, I. Haq, P. Ainsworth, C. Jones, P. Weeks, J. Eden, L. Gibbons, J. Glencross, A. Macleod, K. Poland, C. Mulolland, A. Warke, P. Conn, D. Burns, R. Smith, R. Kamath, J. Webster, I. Hodgins, S. Vercoe, P. Roome, H. Pinnock, J. Patel, A. Ali, N. Hart, R. Davies, N. De-Sousa, C. Neden, M. Danielsen, P. Sharma, S. Galloway, C. Hawkins, R. Oliver, M. Aylward, M. Pattni, G. Irvine, S. Ahmad, C. Rothwell, F. Choudhary, S. Khalaque, S. Short, S. Peters, W. Coulson, N. Roberts, A. Butler, S. Coates, B. Ward, D. Jackson, S. Walton, D. Shepherd, T. Wong, M. Boon, M. Deacon, D. Cornelius, S. Davies, B. Frankel, N. Hargreaves, H. Choi, J. Sumner, T. Myhill, S. Estifanos, D. Geatch, J. Wilkinson, R. Veale, K. Forshaw, R. Hirst, K. Zaman, C. Liley, R. Wastling, P. Mceleny, A. Beattie, P. Cooke, M. Wong, M. Pugsley, C. Dooldeniya, G. Rogers, J. Bennett, P. Jacobs, R. Muvva, M. Adam, R. Fox, N. Thomas, S. Cartwright, R. Reed, S. Randfield, C. A'Court, A. Flynn, A. Halpin, S. Suryani, S. Dobson, L. Lomax, M. Nadaph, I. Munro, J. Goram, H. Stoddart, P. Simmons, J. Shewring, E. Bowen-Simpkins, M. Rickenbach, P. Jacobs, A. Blenkhorn, B. Singh, P. Astridge, W. van Gaal, W. Abhayaratna, P. Thomson, R. Lehman, J. Kilian, D. Coulshed, A. Catanchin, D. Colquhoun, H. Kiat, D. Eccleston, J. French, B. Ayres, P. Blombery, T. Phan, J. Rogers, D. O'Donnell, S. Cheol Bae, H. Gibbs, P. Carroll, G. Starmer, M. Arstall, M. Binnekamp, A. Lee, J. Eikelboom, R. Luton, M. Gupta, A. Shekhar Pandey, S. Cheung, R. Leader, P. Beaudry, F. Ayala-Paredes, J. Berlingieri, J. Heath, G. Poirier, M. du Preez, B. Schweitzer, R. Nadeau, R. Dhillon, T. Hruczkowski, A. Lavoie, R. Parkash, J. Cha, B. Coutu, P. Macdonald, B. Ramjattan, J. Bonet, S. Vizel, P. Angaran, S. Fikry, A. Mowafy, A. Katta, M. Tawfik, M. Nawar, M. Sobhy, S. Kamal Abou Seif, T. Khairy, A. Abd El-Aziz, N. Taha, A. Reda, A. Elbahry, M. Setiha, M. Gamal El Din, M. Elkhadem, A. El-Etreby, D. Kettles, J. Bayat, H. Siebert, A. Horak, Y. Kelfkens, R. Garda, B. Jacobson, T. Pillay, M. Guerra, L. van Zyl, H. Theron, A. Murray, R. Louw, D. Greyling, P. Mntla, S. Ismail, F. Ahmed, J. Engelbrecht, S. Maharajh, W. Oosthuysen, R. Loghdey, V. Ueckermann, W. Al Mahmeed, A. Al Naeemi, G. Yousef, N. Bazargani, M. Alomairi, R. Maruthanayagam, R. Singh, A. Naguib, M. Ibrahim, A. Agrawal, M. Nathani, E. M Esheiba, A. Wassef, R. Gupta, M. Cox, S. Beach, P. Duffy, S. Falkowski, K. Ferrick, M. Franco, W. Michael Kutayli, A. Quick, N. Sharma, V. Wilson, S. Miller, M. Alberts, E. Blumberg, R. Canosa, T. Gutowski, R. Ison, J. Garcia, P. Mullen, H. Noveck, P. Rama, R. Reddy, M. Williams, D. Nishijima, K. Ferdinand, I. Haque, R. Mendelson, S. Pitta, D. Theodoro, C. Treasure, M. Moustafa, C. Cader, W. Pharr, A. Oropallo, G. Platt, J. Gujral, J. Welker, F. Koura. - In: BMJ. - ISSN 1756-1833. - 375:(2021 Oct 27), pp. e066450.1-e066450.10. [10.1136/bmj-2021-066450]
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
C. TondoMembro del Collaboration Group
;
2021
Abstract
OBJECTIVE To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF). SETTING 1317 participating sites in 35 countries. PARTICIPANTS 52 057 patients aged 18 years and older with newly diagnosed atrial fibrillation (up to six weeks' duration) and at least one investigator determined stroke risk factor. MAIN OUTCOME MEASURES Comparisons were made between patients who received cardioversion and those who had no cardioversion at baseline, and between patients who received direct current cardioversion and those who had pharmacological cardioversion. Overlap propensity weighting with Cox proportional hazards models was used to evaluate the effect of cardioversion on clinical endpoints (all cause mortality, non-haemorrhagic stroke or systemic embolism, and major bleeding), adjusting for baseline risk and patient selection. RESULTS 44 201 patients were included in the analysis comparing cardioversion and no cardioversion, and of these, 6595 (14.9%) underwent cardioversion at baseline. The propensity score weighted hazard ratio for all cause mortality in the cardioversion group was 0.74 (95% confidence interval 0.63 to 0.86) from baseline to one year follow-up and 0.77 (0.64 to 0.93) from one year to two year follow-up. Of the 6595 patients who had cardioversion at baseline, 299 had a follow-up cardioversion more than 48 days after enrolment. 7175 patients were assessed in the analysis comparing type of cardioversion: 2427 (33.8%) received pharmacological cardioversion and 4748 (66.2%) had direct current cardioversion. During one year follow-up, event rates (per 100 patient years) for all cause mortality in patients who received direct current and pharmacological cardioversion were 1.36 (1.13 to 1.64) and 1.70 (1.35 to 2.14), respectively. OBJECTIVE To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF). SETTING 1317 participating sites in 35 countries. PARTICIPANTS 52 057 patients aged 18 years and older with newly diagnosed atrial fibrillation (up to six weeks' duration) and at least one investigator determined stroke risk factor. MAIN OUTCOME MEASURES Comparisons were made between patients who received cardioversion and those who had no cardioversion at baseline, and between patients who received direct current cardioversion and those who had pharmacological cardioversion. Overlap propensity weighting with Cox proportional hazards models was used to evaluate the effect of cardioversion on clinical endpoints (all cause mortality, non-haemorrhagic stroke or systemic embolism, and major bleeding), adjusting for baseline risk and patient selection. RESULTS 44 201 patients were included in the analysis comparing cardioversion and no cardioversion, and of these, 6595 (14.9%) underwent cardioversion at baseline. The propensity score weighted hazard ratio for all cause mortality in the cardioversion group was 0.74 (95% confidence interval 0.63 to 0.86) from baseline to one year follow-up and 0.77 (0.64 to 0.93) from one year to two year follow-up.Of the 6595 patients who had cardioversion at baseline, 299 had a follow-up cardioversion more than 48 days after enrolment. 7175 patients were assessed in the analysis comparing type of cardioversion: 2427 (33.8%) received pharmacological cardioversion and 4748 (66.2%) had direct current cardioversion. During one year follow-up, event rates (per 100 patient years) for all cause mortality in patients who received direct current and pharmacological cardioversion were 1.36 (1.13 to 1.64) and 1.70 (1.35 to 2.14), respectively. CONCLUSION In this large dataset of patients with recent onset non-valvular atrial fibrillation, a small proportion were treated with cardioversion. Direct current cardioversion was performed twice as often as pharmacological cardioversion, and there appeared to be no major difference in outcome events for these two cardioversion modalities. For the overall cardioversion group, after adjustments for confounders, a significantly lower risk of mortality was found in patients who received early cardioversion compared with those who did not receive early cardioversion. STUDY REGISTRATION ClinicalTrials.gov NCT01090362.
| File | Dimensione | Formato | |
|---|---|---|---|
|
cardioversion.pdf
accesso aperto
Descrizione: Research
Tipologia:
Publisher's version/PDF
Dimensione
541.81 kB
Formato
Adobe PDF
|
541.81 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
